# EDGAR Filing Document

**Accession Number:** 0001676163
**File Stem:** 0001213900-26-051589
**Filing Date:** 2026-5
**Character Count:** 12034
**Document Hash:** 673425aa1371844ac60444ff3128c29a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-051589.hdr.sgml**: 20260504

**ACCESSION NUMBER**: 0001213900-26-051589

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260504

**DATE AS OF CHANGE**: 20260504

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SS Innovations International, Inc.
- **CENTRAL INDEX KEY:** 0001676163
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 473478854
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94363
- **FILM NUMBER:** 26937781

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 405, 3RD FLOOR, ILABS INFO TECH CENTRE
- **STREET 2:** UDYOG VIHAR, PHASE III
- **CITY:** GURUGRAM
- **NON US STATE TERRITORY:** HARYANA
- **PROVINCE COUNTRY:** K7
- **ZIP:** 122016
- **BUSINESS PHONE:** (954) 478-1410

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 405, 3RD FLOOR, ILABS INFO TECH CENTRE
- **STREET 2:** UDYOG VIHAR, PHASE III
- **CITY:** GURUGRAM
- **NON US STATE TERRITORY:** HARYANA
- **PROVINCE COUNTRY:** K7
- **ZIP:** 122016

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AVRA Medical Robotics, Inc.
- **DATE OF NAME CHANGE:** 20160601
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sudhir Srivastava
- **CENTRAL INDEX KEY:** 0001570020

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G/A

**MAIL ADDRESS:**
- **STREET 1:** C/O AVRA SURGICAL ROBOTICS
- **STREET 2:** ONE LIBERTY PLAZA, 35TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10006

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SRIVASTAVA SUDHIR
- **DATE OF NAME CHANGE:** 20130219

## Exhibit 99.1

**Exhibit 1**

**JOINT FILING AGREEMENT**

Pursuant to Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended, the undersigned agree that the Statement on Schedule 13G to which this exhibit is attached is filed on behalf of each of them. Each of them is individually eligible to use Schedule 13G to which this exhibit is attached. Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.

IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of May 4, 2026.

---

| |
|:---|
| /s/ Sudhir Srivastava |
| Sudhir Srivastava, M.D. |
| Sushruta PVT LTD |
| /s/ Sudhir Srivastava |
| Sudhir Srivastava, M.D., Authorized Signatory |
| Sudhir Srivastava Innovations PTE LTD |
| /s/ Sudhir Srivastava |
| Sudhir Srivastava, M.D., Authorized Signatory |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**(Amendment No. 3)**

**Issuer:** SS Innovations International, Inc.

**Title of Class of Securities:** Common Stock

**CUSIP Number:** —

**Date of Event Which Requires Filing of this Statement:** 03/31/2026

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [ ] Rule 13d-1(c)

- [x] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Sudhir Srivastava, M.D. | Names of Reporting Persons<br>Sudhir Srivastava, M.D. |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>X1 | Citizenship or Place of Organization<br>X1 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>114490054.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>114490054.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>114490054.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>114490054.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>55.8% | Percent of Class Represented by Amount in Row (9)<br>55.8% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

**Comment for Type of Reporting Person:** Consists of (a) 109,585,767 shares of Common Stock of the Company held by Sushruta PVT LTD; (b) 32,000 shares of Common Stock of the Company held by Dr. Srivastava; and (c) Options held by Dr. Srivastava to purchase 4,872,287 shares of Common Stock of the Company. Dr. Srivastava has a 100% interest in Sushruta PVT LTD. Percentage in Row 11 is calculated based on 200,231,535 shares of common stock outstanding as of March 9, 2026, as reported in the issuer's Amended Annual Report on Form 10-K/A for the year ended December 31, 2025.

---

| 1. | Names of Reporting Persons<br>Sushruta PVT LTD | Names of Reporting Persons<br>Sushruta PVT LTD |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>C5 | Citizenship or Place of Organization<br>C5 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>109585767.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>109585767.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>109585767.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>109585767.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>54.7% | Percent of Class Represented by Amount in Row (9)<br>54.7% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** Row 5 and Row 7 consists of  109,585,767 shares of Common Stock of the Company held by Sushruta PVT LTD. Percentage in Row 11 is calculated based on 200,231,535 shares of common stock outstanding as of March 9, 2026, as reported in the issuer's Amended Annual Report on Form 10-K/A for the year ended December 31, 2025.

---

**Item 1(a). Name of Issuer:**
SS Innovations International, Inc.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
1600 SE 15th Street, #512 Fort Lauderdale, FL 33316

**Item 2(a). Name of Person Filing:**
(1) Sudhir Srivastava, M.D. (2) Sushruta PVT LTD

**Item 2(b). Address of Principal Business Office:**
The address for Sudhir Srivastava, M.D., Sushruta PVT LTD and Sudhir Srivastava Innovations PTE LTD is as follows: 1600 SE 15th Street, #512 Fort Lauderdale, FL 33316

**Item 2(c). Citizenship:**
Sudhir Srivastava, M.D. - USA Sushruta PVT LTD - Commonwealth of the Bahamas

**Item 2(d). Title of Class of Securities:**
Common Stock

**Item 2(e). CUSIP Number:**
—

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

(1) Sudhir Srivastava, M.D. - 114,490,054 (2) Sushruta PVT LTD - 109,585,767

**(b) Percent of class:**

(1) Sudhir Srivastava, M.D. - 55.8% (2) Sushruta PVT LTD - 54.7%. All calculations of percentage ownership herein are based upon an aggregate of 200,231,535 shares of common stock outstanding as of March 9, 2026, as reported in the issuer's Amended Annual Report on Form 10-K/A for the year ended December 31, 2025.

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

(1) Sudhir Srivastava, M.D. - 114,490,054 (2) Sushruta PVT LTD - 109,585,767

**(ii) Shared power to vote or to direct the vote:**

(1) Sudhir Srivastava, M.D. - 0 (2) Sushruta PVT LTD - 0

**(iii) Sole power to dispose or to direct the disposition of:**

(1) Sudhir Srivastava, M.D. - 114,490,054 (2) Sushruta PVT LTD - 109,585,767

**(iv) Shared power to dispose or to direct the disposition of:**

(1) Sudhir Srivastava, M.D. - 0 (2) Sushruta PVT LTD - 0

**Item 5. Ownership of Five Percent or Less of a Class.**

[ ] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

The shares of common stock referenced in Item 4, Section (a) above include shares held of record by Sushruta PVT LTD. Dr. Srivastava owns a 100% beneficial interest in Sushruta PVT LTD.

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

—

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Sudhir Srivastava, M.D.**

**Date:** 05/04/2026

**By:** /s/ Sudhir Srivastava

**Name & Title:** Sudhir Srivastava, M.D.

**Sushruta PVT LTD**

**Date:** 05/04/2026

**By:** /s/ Sudhir Srivastava

**Name & Title:** Sudhir Srivastava, M.D., Authorized Signatory